Acorai

Helsingborg, Sweden

Acorai is a medical device manufacturer of non-invasive intracardiac pressure monitoring to improve heart failure management.

$4.4M raised

Dec 2024

Venture - Series Unknown

Top Investors

European Innovation CouncilMayo ClinicCapital Q¬Æ Ventures Inc.Golden Angels InvestorsHealthTech Arkansas

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Acorai raised?

Acorai has raised $4.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2024.

Who are Acorai's investors?

Acorai's investors include European Innovation Council, Mayo Clinic, Capital Q¬Æ Ventures Inc., Golden Angels Investors, HealthTech Arkansas.

Where is Acorai headquartered?

Acorai is headquartered in Helsingborg, Sweden.

What does Acorai do?

Acorai is a medical device manufacturer of non-invasive intracardiac pressure monitoring to improve heart failure management.

What stage is Acorai at?

Acorai is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 2, 2024.

MLA

"Acorai — Funding & Investors." VCBacked, December 2, 2024, https://www.vcbacked.co/company/acorai. Accessed June 3, 2026.

APA

VCBacked. (2024). Acorai — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/acorai

Wikipedia (cite web)

{{cite web |title=Acorai — Funding & Investors |url=https://www.vcbacked.co/company/acorai |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 2, 2024.